(Q36315570)

13 August 2017

title

Proton beam therapy for iris melanomas (English)

1 reference

13 August 2017

Lumbroso-Le Rouic L

1

1 reference

13 August 2017

Delacroix S

2

1 reference

13 August 2017

Dendale R

3

1 reference

13 August 2017

Levy-Gabriel C

4

1 reference

13 August 2017

Feuvret L

5

1 reference

13 August 2017

Noel G

6

1 reference

13 August 2017

Plancher C

7

1 reference

13 August 2017

Nauraye C

8

1 reference

13 August 2017

Garcia P

9

1 reference

13 August 2017

Calugaru V

10

1 reference

13 August 2017

Asselain B

11

1 reference

13 August 2017

Desjardins L

12

1 reference

13 August 2017

publication date

18 November 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

20

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1300-1305

1 reference

Initial management and follow-up of melanocytic iris tumors

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Anterior segment tumors: current concepts and innovations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Ten-year follow-up of helium ion therapy for uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

Iris melanoma: risk factors for metastasis in 169 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Iris seeding following iridocyclectomy for localised iris melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Results of proton radiotherapy for uveal melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Long-term results of proton beam irradiated uveal melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Intraocular recurrence of uveal melanoma after proton beam irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Current results of proton beam irradiation of uveal melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702102

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6702102

1 reference

13 August 2017

1 reference